Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
MEDIAN POLSKA S.A. ZY-,10 | GY3 | 4. oct 2024 | 0.15 | -0.65 |
Median Technologies | 4ZG | 4. oct 2024 | 3.98 | +0.25 |
Mediaseek Inc. | 6WJ | 4. oct 2024 | 1.83 | +1.11 |
Medibank Private Limited | MPV | 4. oct 2024 | 2.20 | +0.92 |
Medical Facilities Corp | 31F | 4. oct 2024 | 8.65 | -1.14 |
Medical Properties Trust Inc | M3P | 4. oct 2024 | 5.15 | +4.66 |
Mediclin AG | MED | 4. oct 2024 | 2.26 | 0.00 |
Medicover B | 5M0B | 4. oct 2024 | 16.06 | -0.62 |
Medicure Inc | NGQ1 | 4. oct 2024 | 0.60 | +2.56 |
MEDICUS PHARMA LTD. | N46 | 4. oct 2024 | 0.57 | 0.00 |
MEDIFAST INC | MDF | 4. oct 2024 | 16.39 | +3.38 |
Medigene AG | MDG1 | 4. oct 2024 | 2.10 | -0.94 |
Medimi | 79T | 4. oct 2024 | 0.00 | -66.67 |
Medincell S.A. | MEB | 4. oct 2024 | 15.12 | -1.31 |
MEDIOBANCA S.P.A.UNSP.ADR | ME90 | 4. oct 2024 | 14.50 | -1.36 |
Mediobanca SpA | ME9 | 4. oct 2024 | 14.72 | -2.29 |
Medion AG | MDN | 4. oct 2024 | 14.50 | -0.68 |
Medios AG | ILM1 | 4. oct 2024 | 15.20 | -1.04 |
Medipal Holdings Corporation | 59Z | 4. oct 2024 | 15.70 | +0.64 |
Medipharm Labs Corp | MLZ | 4. oct 2024 | 0.04 | +5.24 |
Medistim | MD1 | 4. oct 2024 | 14.60 | -2.34 |
MEDIVIR AB | MVR0 | 4. oct 2024 | 0.22 | -5.19 |
MediWound Ltd. - Ordinary Shares | M8W | 4. oct 2024 | 14.80 | -1.33 |
Medley Inc. | 3YV | 4. oct 2024 | 23.80 | +0.85 |
Medmira Inc | 47M | 4. oct 2024 | 0.05 | +5.43 |
Mednax, Inc. | PDC | 4. oct 2024 | 10.60 | -1.85 |
Medpace Holdings, Inc. | 01P | 4. oct 2024 | 312.20 | +2.06 |
MedPeer Inc | 9UN | 4. oct 2024 | 3.50 | +1.74 |
Medtronic plc. Ordinary Shares | 2M6 | 4. oct 2024 | 79.84 | -0.16 |
Meeka Gold Ltd | 1KX0 | 4. oct 2024 | 0.03 | +1.49 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.